Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIBB 1464 vs Pravastatin in Hyperlipemic Healthy Males
NCT02229773Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2000
- Primary completion
- May 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of BIBB 1464 in hypercholesterolemia (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Percentage change of LDL plasma cholesterol at 2 weeks and Percentage change of total plasma cholesterol at 2 weeks. Started Jan 2000; status: completed.
02
Drugs
BIBB 1464
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02229773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229773.